Table 2.
miRNAs | Specificity | Localization | References |
---|---|---|---|
miR-26b ↑ | AD, PD | CNS, Blood | [43] |
miR-206 ↑ | AD, ALS | CSF | [44] |
miR-34a ↑ | AD, PD, HD | CNS, Blood | [45] |
miR-126 ↑ | AD, PD | CNS | [46] |
miR-9 ↓ | AD | Cortex | [47] |
miR-221 ↓ | AD | Cortex | [48] |
miR-98 ↑ | AD | Cortex | [49] |
miR-330 ↓ | AD, HD | CNS | [50] |
miR-19 ↓ | AD, PD | CNS | [51] |
miR-30 ↓ | AD, PD | Blood, CSF | [17] |
miR-375 ↓ | AD | CSF | [53] |
miR-7 ↓ | PD | CNS | [52] |
miR-124 ↓ | PD, AD | CNS | [54] |
miR-133b ↓ | PD, HD, ALS | CNS, Cortex | [74] |
miR-153 ↓ | PD | CNS | [55] |
miR-443 ↑ | PD | CNS | [56] |
miR-494 ↑ | PD | CSF | [57] |
miR-34b/c ↓ | PD, AD, HD | CNS, Blood | [58] |
miR-205 ↓ | PD | CNS | [59] |
miR-27a ↓ | PD, ALS | CNS | [60] |
miR-105 ↓ | PD, AD | CSF | [60] |
miR-103 ↑ | PD, AD | CNS, Blood | [60] |
miR 4639 5p ↓ | PD | CNS | [61] |
miR-21 ↑ | PD, AD | Lymphocytes, CSF, Blood | [62] |
miR-331-5p ↑ | PD | CNS, Blood | [63] |
miR-132 ↓ | HD, ALS, AD | CNS, CSF, Cortex, Cerebellum | [64] |
miR-125b ↓ | HD, AD | CNS, Hippocampus | [65] |
miR-146a ↓ | HD, AD, ALS | CSF, Spinal cord | [66] |
miR-196a ↓ | HD | Cortex | [67] |
miR-9 ↑ | HD, AD, ALS | CNS | [68] |
miR-124 ↑ | HD, AD | CSF, Hippocampus, Cortex | [69] |
miR-29a ↑ | HD, AD, PD | Cortex, Blood | [69] |
miR-129-5p ↑ | ALS. PD | Cerebellum, CSF | [70] |
miR-27a/b ↓ | ALS | Monocytes CD14 + CD16- | [72] |
miR-335-5p ↑ | ALS | CNS | [72] |
miR-151b ↓ | ALS, HD, AD | Cortex, CNS | [73] |
miR-221-3p ↓ | ALS | CNS | [73] |
miR-130a-3p ↓ | ALS | CNS | [73] |
↑ = miRNA upregulated in related disease; ↓ = miRNA downregulated in related disease. AD = Alzheimer’s disease; PD = Parkinson’s disease; HD = Huntington’s disease; ALS = Amyotrophic lateral sclerosis; CNS = central nervous system; CSF = cerebrospinal fluid.